D Bennabi, A Yrondi, T Charpeaud, J-B Genty, S Destouches, S Lancrenon, N Allaili, F Bellivier, T Bougerol, V Camus, O Doumy, J-M Dorey, F Haesebaert, J Holtzmann, C Lançon, M Lefebvre, F Moliere, I Nieto, C Rabu, R Richieri, L Schmitt, F Stephan, G Vaiva, M Walter, M Leboyer, W El-Hage, B Aouizerate, E Haffen, P-M Llorca, P Courtet
Journal: BMC psychiatry 2019;19(1):50
PMID: 30700272
BACKGROUND
Recommendations for pharmacological treatments of major depression with specific comorbid psychiatric conditions are lacking.
METHOD
The French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of depression based on the RAND/UCLA Appropriatneness Method. Recommendations for lines of treatment are provided by the scientific committee after data analysis and interpretation of the results of a survey of 36 psychiatrist experts in the field of major depression and its treatments.
RESULTS
The expert guidelines combine scientific evidence and expert clinician's opinion to produce recommendations for major depression with comorbid anxiety disorders, personality disorders or substance use disorders and in geriatric depression.
CONCLUSION
These guidelines provide direction addressing common clinical dilemmas that arise in the pharmacologic treatment of major depression with comorbid psychiatric conditions.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.